AU3772697A - Pharmaceutical composition to be administered orally - Google Patents

Pharmaceutical composition to be administered orally

Info

Publication number
AU3772697A
AU3772697A AU37726/97A AU3772697A AU3772697A AU 3772697 A AU3772697 A AU 3772697A AU 37726/97 A AU37726/97 A AU 37726/97A AU 3772697 A AU3772697 A AU 3772697A AU 3772697 A AU3772697 A AU 3772697A
Authority
AU
Australia
Prior art keywords
administered orally
pharmaceutical composition
composition
fat
sugar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37726/97A
Inventor
Jean-Claude Maurel
Yolande Sancy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LABORATOIRES THELFAR
Maurel Sante
Original Assignee
THELFAR LAB
Maurel Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THELFAR LAB, Maurel Sante filed Critical THELFAR LAB
Publication of AU3772697A publication Critical patent/AU3772697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention concerns a pharmaceutical composition to be administered orally with absorption of at least one active principle preferably through the mucous membranes of the mouth, comprising an excipient containing at least one sugar and optionally a texturing agent, characterised in that said excipient further contains one fat or one vegetable or animal oil. The composition constituted a perfectly homogeneous mixture, containing at least 10 % unconnected water, 1 to 15 % fat or oil and 50 to 80 % sugar or sweetening agents. The active principles of the medicines can be brought in solid or liquid form, soluble or insoluble in water or the fats, hygroscopic or not; they can be indifferently absorbed at any level of the digestive tube; however the composition isi advantageously adapted to absorption through the mucous membranes of the mouth. The compositions are in the form of tablets, pastes, lozenges.
AU37726/97A 1996-07-12 1997-07-11 Pharmaceutical composition to be administered orally Abandoned AU3772697A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9608740 1996-07-12
FR9608740A FR2750859B1 (en) 1996-07-12 1996-07-12 PHARMACEUTICAL COMPOSITION INTENDED FOR ORAL ADMINISTRATION WITH ABSORPTION OF AT LEAST ONE ACTIVE INGREDIENT THROUGH THE MUCOSA OF THE MOUTH
PCT/FR1997/001277 WO1998002140A1 (en) 1996-07-12 1997-07-11 Pharmaceutical composition to be administered orally

Publications (1)

Publication Number Publication Date
AU3772697A true AU3772697A (en) 1998-02-09

Family

ID=9493994

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37726/97A Abandoned AU3772697A (en) 1996-07-12 1997-07-11 Pharmaceutical composition to be administered orally

Country Status (8)

Country Link
EP (1) EP0910341B1 (en)
AT (1) ATE270095T1 (en)
AU (1) AU3772697A (en)
CA (1) CA2295866A1 (en)
DE (1) DE69729729T2 (en)
ES (1) ES2224261T3 (en)
FR (1) FR2750859B1 (en)
WO (1) WO1998002140A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786665B1 (en) * 1998-12-08 2001-02-23 Maurel Sante BASIC POLYOL COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS AND FOOD SUPPLEMENTS INCLUDING SUCH COMPOSITIONS AND METHODS OF PREPARING THE SAME
GB0114746D0 (en) * 2001-06-16 2001-08-08 Boots Co Plc Medicinal composition
GB0229258D0 (en) * 2002-12-16 2003-01-22 Boots Healthcare Int Ltd Medicinal compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50157517A (en) * 1974-06-14 1975-12-19
JPS5732221A (en) * 1980-08-05 1982-02-20 Morinaga & Co Ltd Preparation of tablet confection containing lactobacillus bifidus
US5284659A (en) * 1990-03-30 1994-02-08 Cherukuri Subraman R Encapsulated flavor with bioadhesive character in pressed mints and confections
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
JPH08208456A (en) * 1995-01-31 1996-08-13 Daikyo Yakuhin Kogyo Kk Oral administration medicine

Also Published As

Publication number Publication date
ES2224261T3 (en) 2005-03-01
CA2295866A1 (en) 1998-01-22
ATE270095T1 (en) 2004-07-15
DE69729729T2 (en) 2005-08-04
EP0910341A1 (en) 1999-04-28
FR2750859A1 (en) 1998-01-16
DE69729729D1 (en) 2004-08-05
WO1998002140A1 (en) 1998-01-22
FR2750859B1 (en) 1999-01-22
EP0910341B1 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
AP1637A (en) Celecoxib compositions.
DE3065420D1 (en) Pharmaceutical composition containing sanguinaria and galangal suitable for treatment of periodentitis and tumours
LT2000064A (en) Flash-melt oral dosage formulation
CA2179682A1 (en) Pharmaceutical, orally applicable composition
TNSN97114A1 (en) GRANULE FOR THE PREPARATION OF RAPID DISINTEGRATION AND DISSOLUTION COMPOSITIONS COMPRISING A HIGH CONTENT OF AN ACTIVE INGREDIENT
SE8801732L (en) NEW COMPOSITION
IL96995A0 (en) Pharmaceutical compositions containing pimobendan and their preparation
NO20030897D0 (en) Process for the preparation of pharmaceutical compositions for use with wet gelatin formulations
PL319585A1 (en) Vitamins and calcium, containing therapeutic composition in the unit galenic form of tablets, method of obtaining same and application thereof
DE68901014D1 (en) ANTI-INFLAMMATORY-PROTECTED IBUPROFEN, WHICH DOES NOT HAVE BITTER TASTE, NO THROAT, AND NO INTESTINAL TOXICITY IN AQUEOUS SOLUTION.
DE3669106D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING FLAVANOLIGNANES AND PHOSPHOLIPIDES AS ACTIVE INGREDIENTS.
HU9302971D0 (en) Chewable antacid preparations
BR0011447A (en) Composition comprising alkaline sphingomyelinase for application as a dietary preparation, food supplement or pharmaceutical product
ZA971134B (en) Multifunctional fat absorption and blood cholesterol reducing formulation.
WO2001028526A3 (en) Gastroresistant tablets for alimentary, dietetic and therapeutic use
AU3772697A (en) Pharmaceutical composition to be administered orally
KR920702225A (en) Pharmaceutical composition
EP1741344A3 (en) Chewing gum including a liquid sorbitol/mannitol/glycerin blend
NZ505933A (en) Incorporation of cholesterol lowering agents into confectionery dosage forms
JPS5661311A (en) Thial amide or prolonged pharmaceutical preparation comprising its salt
JP4655338B2 (en) Drugs for improving iron deficiency anemia
ATE194498T1 (en) ANHYDROUS LACTULOSE-BASED AGENT
ATE227519T1 (en) CALCIUM-RICH JELLY PASTE WITHOUT SUGAR
FR2709962A1 (en) Compositions based on magnesium and vitamin B6 for the prevention or treatment of premenstrual syndrome
RU97106923A (en) HEPATOPROTECTOR, BILITIOUS, ANTIHELMINTH MEANS "KUMIVIT"